About this document

Cardiovascular Benefits of Obesity Therapies An Overview of Obesity Medicines and Metabolic Bariatric Surgery Villelabeitia Et Al. 2026 by cantiag is a document available to read on EtoBox.

The document reviews the cardiovascular benefits of obesity therapies, including obesity medicines and metabolic bariatric surgery (MBS). It highlights that obesity is a significant risk factor for cardiovascular disease (CVD) and discusses how contemporary obesity treatments, particularly glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and MBS, can improve cardiovascular outcomes beyond traditional risk factor management. The findings suggest that sustained weight loss of at least 10% is crucial for

Author

cantiag

Language

EN